Drug Name:
ASTEPRO Rx
Generic Name and Formulations:
Azelastine HCl 0.15% (205.5mcg/spray;) aqueous nasal spray; contains benzalkonium chloride.
Company:
Meda Pharmaceuticals
Therapeutic Use:
Indications for ASTEPRO:
Seasonal and perennial allergic rhinitis.
Adult:
Seasonal: 1 or 2 sprays in each nostril twice daily or 2 sprays in each nostril once daily. Perennial: 2 sprays in each nostril twice daily.
Children:
<6yrs: see full labeling. Seasonal or perennial (6–11yrs): 1 spray in each nostril twice daily.
Warnings/Precautions:
Avoid eyes, mouth. Pregnancy. Nursing mothers.
Pharmacological Class:
Antihistamine.
Interactions:
Potentiates CNS depression with alcohol, other CNS depressants. Caution with other antihistamines.
Adverse Reactions:
Bitter taste, nasal discomfort, epistaxis, headache, fatigue, somnolence, sneezing.
How Supplied:
Spray—30mL (200 sprays)
Endocrinology Advisor Articles
- Insulin Analogs vs Regular Human Insulin for Type 2 Diabetes
- Trends in Bisphosphonate Use and Hip Fracture Rates in Denmark
- Primary Characteristics of PCOS Predictive of Obstetric Complications
- Gender-Affirming Hormonal Treatment and Long-Term Bone Safety
- Maternal Thyroid Function in Pregnancy Linked to Childhood Risk for Disease
- Head-to-Head Comparison of Professional vs Personal CGM Systems in T1D
- Familial Hypercholesterolemia: An Underdiagnosed Disease Gets a Second Look
- Academy of Nutrition and Dietetics Does Not Recommend Routine Supplements for Chronic Disease Prevention
- Insulin Analogs vs Regular Human Insulin for Type 2 Diabetes
- Depression, Anxiety Predict Physical Health Indices As Strongly As Obesity
- Predictors of Disordered Eating Behaviors in Teens with Type 1 Diabetes
- Many Female Health Care Workers Live in Poverty
- Increase in Brand-Name Drug Cost Mainly Due to Existing Drugs
- FDA Committee Votes on Oral T1D Treatment Sotagliflozin
- Elevated Plasma Agouti-Related Protein May Be a Marker for Cushing Disease
Sign Up for Free e-Newsletters
Check out what's trending
CME Focus
TSH-Receptor Antibodies, Clinical Applications and Clinical Relevance
CME|CE
5.00 Credits
Blocking TSH-Receptor Antibodies in Autoimmune Thyroid Disease
CME|CE
4.00 Credits